卵巢癌术后血浆CA125的半衰期与预后的关系

RELATION BETWEEN POSTOPERATIVE PROGNOSIS AND HALF LIFE PERIOD OF SERUM CA125

  • 摘要: 对18例经手术和病理证实为卵巢上皮癌患者,术后施以顺铂、阿霉素、环磷酰胺(PAC方案)联合化疗。在术前、化疗及随访过程中采取静脉血用放射免疫法测定CA125浓度。由化疗第一、第三疗程前CA125水平,根据Buller等提供的公式计算半衰期。结果发现18例患者中半衰期>20天者10例(56%),有8例出现复发或死亡;而半衰期<20天的8例则存活良好。提示化疗早期CA125水平及血浆半衰期对卵巢癌患者的预后评定有一定的价值,检测该指标可及时发现耐药或复发,从而及早采取相应的治疗措施。

     

    Abstract: Eighteen cases with ovarian epithelial carcinoma proved surgically and pathologicallywere performed by chemotherapy combined with cisplatin,adriamycin and cyclophosphamide(PAC) post-operatively. During preoperation, chemotherapy and follow - up, venous blood was sampled to measureCA125 concentration with radio-immunity therapy- The half life period was calculated by CA125 level be-fore the first and third course of the treatment of chemotherapy and Buller's formula. The results showedthat the speed of CA125 level's decreasing in the early period of chemotherapy was related to the progno-sis. Of 18 patients, ten(56 % ) had the half life period20ds and eight of them recurrence and death,whilethe eight wh0se half life period20ds survived quite well. This suggested CA125 level of the early period ofchemotherapy and serum half life period had earlier and more reliable value. If used clinically,it may help tofind drug resistance or recurrence in time so as to take corresponding treating measures early.

     

/

返回文章
返回